Biomx Inc (PHGE)
Official siteINDUSTRIALS • BIOTECHNOLOGY • AMEX
Market Cap: $5.00M
Last updated: Sep 10, 2026 at 8:00 PM ET
Biomx Inc (PHGE) Financials: Revenue, Profit and Cash Flow
Biomx reported revenue of -$2.88M for the fiscal year ended Dec 31, 2025, down 111.3% from the year before. That year, net income was -$36.20M, operating cash flow was -$26.39M and free cash flow was -$26.39M. The quarter ended Jun 30, 2026 had revenue of $322.00K and net income of -$3.85M.
Revenue and Margins
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | -$2.88M | -111.3% | N/A | N/A | N/A |
| Dec 2024 | $25.36M | +7004.8% | -7.1% | -153.9% | -69.9% |
| Dec 2023 | $357.00K | N/A | -244.0% | -7754.9% | -7330.3% |
| Dec 2022 | -$1.94M | N/A | N/A | N/A | N/A |
| Dec 2021 | -$699.00K | N/A | N/A | N/A | N/A |
| Dec 2020 | $0 | N/A | N/A | N/A | N/A |
| Dec 2019 | $0 | N/A | N/A | N/A | N/A |
| Dec 2018 | $0 | N/A | N/A | N/A | N/A |
| Jun 2018 | N/A | N/A | N/A | N/A | N/A |
| Dec 2017 | N/A | N/A | N/A | N/A | N/A |
Income Statement
In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Jun 2026, the net loss narrowed from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Jun 2018 | Dec 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -$2.88M | $25.36M | $357.00K | -$1.94M | -$699.00K | $0 | $0 | $0 | N/A | N/A |
| Cost of revenue | $2.92M | $1.80M | $871.00K | $2.52M | $2.56M | $2.18M | $318.00K | $210.00K | N/A | $95.00K |
| Gross profit | -$2.92M | -$1.80M | -$871.00K | -$2.65M | -$2.56M | -$2.18M | -$405.00K | -$210.00K | N/A | -$95.00K |
| Research and development | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $4.74M |
| Operating income | -$32.91M | -$39.03M | -$27.68M | -$27.22M | -$35.46M | -$30.26M | -$22.21M | -$13.14M | -$1.03K | -$7.37M |
| Net income | -$36.20M | -$17.73M | -$26.17M | -$28.32M | -$36.23M | -$30.09M | -$20.56M | -$12.72M | -$1.03K | -$6.43M |
| EBITDA | -$32.55M | -$14.99M | -$25.96M | -$26.17M | -$33.41M | -$28.08M | -$20.25M | -$12.51M | N/A | -$6.34M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $322.00K | -$12.05M | -$4.50M | -$706.00K | -$70.00K | $908.00K | -$1.24M | $20.64M | $13.88M | -$7.92M | $87.00K | $89.00K |
| Gross profit | N/A | N/A | -$1.15M | -$1.24M | -$292.00K | -$236.00K | $2.75M | -$322.00K | -$331.00K | -$229.00K | N/A | -$219.00K |
| Operating income | N/A | -$1.30M | -$7.20M | -$8.54M | -$7.43M | -$7.76M | $16.68M | -$10.53M | -$9.72M | -$6.79M | -$5.27M | -$7.79M |
| Net income | -$3.85M | -$19.14M | -$13.34M | -$9.17M | -$6.04M | -$7.66M | -$14.51M | $9.64M | $4.47M | -$17.33M | -$5.49M | -$7.91M |
Balance Sheet
As of Dec 2025, total debt of $4.94M exceeded cash and equivalents by $583.00K. Shareholder equity was negative, at -$1.30M, as total liabilities of $7.08M exceeded total assets of $5.78M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | $5.78M | $43.23M | $25.03M | $45.53M | $77.99M | $70.36M | $92.12M | $45.33M | $13.99M |
| Current assets | $5.58M | $20.52M | $17.63M | $36.88M | $66.64M | $60.67M | $84.53M | $39.89M | $8.47M |
| Cash and equivalents | $4.36M | $16.86M | $14.91M | $31.33M | $62.10M | $36.48M | $72.26M | $8.60M | $6.99M |
| Total liabilities | $7.08M | $19.09M | $21.95M | $24.49M | $30.45M | $12.89M | $7.67M | $2.53M | $2.46M |
| Short-term debt | $4.94M | $1.88M | $5.79M | $5.10M | $8.25M | $3.18M | $3.63M | $193.00K | $40.00K |
| Long-term debt | $0 | N/A | $5.40M | $10.59M | $14.41M | $0 | N/A | $500.00K | N/A |
| Shareholder equity | -$1.30M | $24.15M | $3.08M | $21.04M | $47.53M | $57.47M | $84.46M | $42.80M | $11.53M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $28.19M | $3.25M | $70.24M | $26.17M | $38.05M | $45.65M | $43.23M | $59.98M | $68.62M | $81.61M | $25.03M | $33.06M |
| Total liabilities | $10.56M | $4.13M | $71.54M | $15.68M | $18.89M | $21.16M | $19.09M | $22.08M | $48.73M | $58.73M | $21.95M | $24.90M |
| Cash and equivalents | $347.00K | $1.17M | $4.96M | $6.92M | $14.05M | $20.12M | $17.81M | $23.54M | $31.61M | $43.01M | $14.91M | $22.45M |
| Shareholder equity | $10.87M | -$881.00K | -$1.30M | $10.49M | $19.16M | $24.50M | $24.15M | $37.90M | $27.43M | -$9.54M | $3.08M | $8.15M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Jun 2018 | Dec 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$26.39M | -$36.98M | -$21.29M | -$29.09M | -$27.57M | -$24.45M | -$17.58M | -$11.30M | -$30 | -$4.10M |
| Capital expenditures | $2.00K | $30.00K | $50.00K | $112.00K | $3.68M | $1.01M | $1.31M | $137.00K | $0 | $850.00K |
| Free cash flow | -$26.39M | -$37.01M | -$21.34M | -$29.20M | -$31.25M | -$25.46M | -$18.89M | -$11.44M | -$30 | -$4.95M |
| Investing cash flow | $108.00K | $715.00K | $1.95M | -$2.11M | $16.17M | -$10.86M | $19.74M | -$30.04M | N/A | -$2.12M |
| Financing cash flow | $13.19M | $38.37M | $2.90M | $292.00K | $37.28M | $134.00K | $61.55M | $43.04M | $460 | $12.95M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$1.17M | -$5.41M | -$4.39M | -$7.18M | -$6.11M | -$8.71M | -$6.29M | -$8.10M | -$11.24M | -$11.36M | -$6.24M | -$5.92M |
| Capital expenditures | N/A | $0 | $0 | $2.00K | $0 | $0 | $11.00K | $10.00K | $9.00K | $7.00K | $7.00K | $32.00K |
| Free cash flow | N/A | -$5.41M | -$4.39M | -$7.18M | -$6.11M | -$8.71M | -$6.30M | -$8.11M | -$11.25M | -$11.36M | -$6.25M | -$5.95M |
Frequently Asked Questions About PHGE
What is Biomx's annual revenue?
Biomx reported revenue of -$2.88M for the fiscal year ended Dec 31, 2025.
How fast is Biomx's revenue growing?
Revenue was down 111.3% for the fiscal year ended Dec 31, 2025 compared with the year before.
Is Biomx profitable?
No. Biomx reported net income of -$36.20M for the fiscal year ended Dec 31, 2025.
How much free cash flow does PHGE generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$26.39M minus capital expenditures of $2.00K produced free cash flow of -$26.39M.
How much debt does Biomx have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $0, short-term debt of $4.94M and cash and equivalents of $4.36M.
PHGE pages: Overview, Financials